Smith & Nephew (SNN) Buys Brainlab, Braces Robotic Ecosystem
Zacks Investment Research | Jun 06, 2019 10:52PM ET
Recently Smith & Nephew (LON:SN) plc (NYSE:SNN) closed its acquisition of the Brainlab orthopaedic joint reconstruction business. The deal, initiated in March 2019, is in line with the company’s strategy to invest in cutting-edge technologies, which will help accelerate its presence in the multi-asset digital surgery and robotic ecosystem space.
Financial terms of this acquisition deal were kept under wraps. Apart from the orthopedic major’sbusiness purchase, the transaction includes certain intangible assets as well as the orthopaedic Brainlab salesforce, which will be integrated into the company’s robotics commercial organisation.
Brainlab Business at a Glance
This business provides digital workflow tools starting from pre-operative planning to intraoperative navigation to postoperative evaluation and sharing. It already has a huge customer base, which after getting incorporated into Smith & Nephew, will help the company expand its niche market. Currently, the technology is being used in more than 40,000 orthopaedic cases each year at more than 500 accounts worldwide.
Strategic Implication of the Business
With the completion of the acquisition, Smith & Nephew can now access a broad range of Brainlab technologies in cloud computing, tracking, augmented reality, robotics, AI, machine learning, image fusion and anatomical segmentation.
Smith & Nephew SNATS, Inc. Price
Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.